Debate on Treating Oligometastatic Metastatic Hormone-sensitive Prostate Cancer: The Argument for New-generation Hormone Therapy and Radiation Therapy to the Prostate

Detalles Bibliográficos
Autor principal: Saad, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Letter: Open Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789384/
https://www.ncbi.nlm.nih.gov/pubmed/36573247
http://dx.doi.org/10.1016/j.euros.2022.10.020
_version_ 1784858941504618496
author Saad, Fred
author_facet Saad, Fred
author_sort Saad, Fred
collection PubMed
description
format Online
Article
Text
id pubmed-9789384
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97893842022-12-25 Debate on Treating Oligometastatic Metastatic Hormone-sensitive Prostate Cancer: The Argument for New-generation Hormone Therapy and Radiation Therapy to the Prostate Saad, Fred Eur Urol Open Sci Research Letter: Open Science Elsevier 2022-12-15 /pmc/articles/PMC9789384/ /pubmed/36573247 http://dx.doi.org/10.1016/j.euros.2022.10.020 Text en © 2022 The Author. Published by Elsevier B.V. on behalf of European Association of Urology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter: Open Science
Saad, Fred
Debate on Treating Oligometastatic Metastatic Hormone-sensitive Prostate Cancer: The Argument for New-generation Hormone Therapy and Radiation Therapy to the Prostate
title Debate on Treating Oligometastatic Metastatic Hormone-sensitive Prostate Cancer: The Argument for New-generation Hormone Therapy and Radiation Therapy to the Prostate
title_full Debate on Treating Oligometastatic Metastatic Hormone-sensitive Prostate Cancer: The Argument for New-generation Hormone Therapy and Radiation Therapy to the Prostate
title_fullStr Debate on Treating Oligometastatic Metastatic Hormone-sensitive Prostate Cancer: The Argument for New-generation Hormone Therapy and Radiation Therapy to the Prostate
title_full_unstemmed Debate on Treating Oligometastatic Metastatic Hormone-sensitive Prostate Cancer: The Argument for New-generation Hormone Therapy and Radiation Therapy to the Prostate
title_short Debate on Treating Oligometastatic Metastatic Hormone-sensitive Prostate Cancer: The Argument for New-generation Hormone Therapy and Radiation Therapy to the Prostate
title_sort debate on treating oligometastatic metastatic hormone-sensitive prostate cancer: the argument for new-generation hormone therapy and radiation therapy to the prostate
topic Research Letter: Open Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9789384/
https://www.ncbi.nlm.nih.gov/pubmed/36573247
http://dx.doi.org/10.1016/j.euros.2022.10.020
work_keys_str_mv AT saadfred debateontreatingoligometastaticmetastatichormonesensitiveprostatecancertheargumentfornewgenerationhormonetherapyandradiationtherapytotheprostate

Ejemplares similares